Abstract
Numerous investigations have described cutaneous and systemic physiological and pharmacological aberrations in atopic dermatitis and the atopic diathesis. Some of these studies set the stage for a focus upon cyclic nucleotide abnormalities. Elevated leukocyte cyclic AMP‐phosphodiesterase accounts for low intracellular cyclic AMP levels in atopic dermatitis. The resultant permissive effect correlates with abnormal functional parameters such as increased basophil histamine release and in vitro IgE synthesis. In vitro and clinical use of phosphodiesterase inhibitors corrects abnormal parameters and may indicate future therapeutic directions.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 41-46 |
| Number of pages | 6 |
| Journal | Allergy |
| Volume | 44 |
| DOIs | |
| State | Published - Jan 1 1989 |
Fingerprint
ASJC Scopus subject areas
- Immunology and Allergy
- Immunology
Cite this
Pharmacological abnormalities in atopic dermatitis. / Hanifin, Jon.
In: Allergy, Vol. 44, 01.01.1989, p. 41-46.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Pharmacological abnormalities in atopic dermatitis
AU - Hanifin, Jon
PY - 1989/1/1
Y1 - 1989/1/1
N2 - Numerous investigations have described cutaneous and systemic physiological and pharmacological aberrations in atopic dermatitis and the atopic diathesis. Some of these studies set the stage for a focus upon cyclic nucleotide abnormalities. Elevated leukocyte cyclic AMP‐phosphodiesterase accounts for low intracellular cyclic AMP levels in atopic dermatitis. The resultant permissive effect correlates with abnormal functional parameters such as increased basophil histamine release and in vitro IgE synthesis. In vitro and clinical use of phosphodiesterase inhibitors corrects abnormal parameters and may indicate future therapeutic directions.
AB - Numerous investigations have described cutaneous and systemic physiological and pharmacological aberrations in atopic dermatitis and the atopic diathesis. Some of these studies set the stage for a focus upon cyclic nucleotide abnormalities. Elevated leukocyte cyclic AMP‐phosphodiesterase accounts for low intracellular cyclic AMP levels in atopic dermatitis. The resultant permissive effect correlates with abnormal functional parameters such as increased basophil histamine release and in vitro IgE synthesis. In vitro and clinical use of phosphodiesterase inhibitors corrects abnormal parameters and may indicate future therapeutic directions.
UR - http://www.scopus.com/inward/record.url?scp=85047689991&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85047689991&partnerID=8YFLogxK
U2 - 10.1111/j.1398-9995.1989.tb02454.x
DO - 10.1111/j.1398-9995.1989.tb02454.x
M3 - Article
VL - 44
SP - 41
EP - 46
JO - Allergy: European Journal of Allergy and Clinical Immunology
JF - Allergy: European Journal of Allergy and Clinical Immunology
SN - 0108-1675
ER -